The Bormioli Pharma acquisition brought Gerresheimer to a new level in terms of revenues and EBITDA and is strengthening our market position. It was also a prerequisite for building a strong moulded ...
Q3 2025 Earnings Call October 21, 2025 9:00 AM EDTCompany ParticipantsChinmay Trivedi - Senior Vice President of Investor ...
The GLP-1 agonist at the center of Pfizer’s upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability,” ...
The ASX 200 has bounced out of the blocks, gaining 0.9 per cent to start the week. The local market was supported by buying in the banks and a rebound in CSL after fears eased about new US tariffs on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback